3.25.4 html 152 269 1 false 70 0 false 7 false false R1.htm 0000001 - Document - Cover Sheet http://www.vallon-pharma.com/role/Cover Cover Cover 1 false false R2.htm 0000002 - Document - Audit Information Sheet http://www.vallon-pharma.com/role/AuditInformation Audit Information Cover 2 false false R3.htm 9952151 - Statement - Consolidated Balance Sheets Sheet http://www.vallon-pharma.com/role/ConsolidatedBalanceSheets Consolidated Balance Sheets Statements 3 false false R4.htm 9952152 - Statement - Consolidated Balance Sheets (Parenthetical) Sheet http://www.vallon-pharma.com/role/ConsolidatedBalanceSheetsParenthetical Consolidated Balance Sheets (Parenthetical) Statements 4 false false R5.htm 9952153 - Statement - Consolidated Statements of Operations Sheet http://www.vallon-pharma.com/role/ConsolidatedStatementsofOperations Consolidated Statements of Operations Statements 5 false false R6.htm 9952154 - Statement - Consolidated Statements of Cash Flows Sheet http://www.vallon-pharma.com/role/ConsolidatedStatementsofCashFlows Consolidated Statements of Cash Flows Statements 6 false false R7.htm 9952155 - Statement - Consolidated Statements of Changes in Stockholders??? Equity Sheet http://www.vallon-pharma.com/role/ConsolidatedStatementsofChangesinStockholdersEquity Consolidated Statements of Changes in Stockholders??? Equity Statements 7 false false R8.htm 9952156 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS Sheet http://www.vallon-pharma.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESS ORGANIZATION AND DESCRIPTION OF BUSINESS Notes 8 false false R9.htm 9952157 - Disclosure - LIQUIDITY Sheet http://www.vallon-pharma.com/role/LIQUIDITY LIQUIDITY Notes 9 false false R10.htm 9952158 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Sheet http://www.vallon-pharma.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Notes 10 false false R11.htm 9952159 - Disclosure - PROPERTY AND EQUIPMENT Sheet http://www.vallon-pharma.com/role/PROPERTYANDEQUIPMENT PROPERTY AND EQUIPMENT Notes 11 false false R12.htm 9952160 - Disclosure - LEASES Sheet http://www.vallon-pharma.com/role/LEASES LEASES Notes 12 false false R13.htm 9952161 - Disclosure - ACCRUED EXPENSES Sheet http://www.vallon-pharma.com/role/ACCRUEDEXPENSES ACCRUED EXPENSES Notes 13 false false R14.htm 9952162 - Disclosure - STOCKHOLDERS EQUITY Sheet http://www.vallon-pharma.com/role/STOCKHOLDERSEQUITY STOCKHOLDERS EQUITY Notes 14 false false R15.htm 9952163 - Disclosure - STOCK-BASED COMPENSATION Sheet http://www.vallon-pharma.com/role/STOCKBASEDCOMPENSATION STOCK-BASED COMPENSATION Notes 15 false false R16.htm 9952164 - Disclosure - SEGMENT REPORTING Sheet http://www.vallon-pharma.com/role/SEGMENTREPORTING SEGMENT REPORTING Notes 16 false false R17.htm 9952165 - Disclosure - COMMITMENTS AND CONTINGENCIES Sheet http://www.vallon-pharma.com/role/COMMITMENTSANDCONTINGENCIES COMMITMENTS AND CONTINGENCIES Notes 17 false false R18.htm 9952166 - Disclosure - INCOME TAX Sheet http://www.vallon-pharma.com/role/INCOMETAX INCOME TAX Notes 18 false false R19.htm 9952167 - Disclosure - SUBSEQUENT EVENTS Sheet http://www.vallon-pharma.com/role/SUBSEQUENTEVENTS SUBSEQUENT EVENTS Notes 19 false false R20.htm 995445 - Disclosure - Insider Trading Arrangements Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingArrangements Insider Trading Arrangements Notes 20 false false R21.htm 995447 - Disclosure - Insider Trading Policies and Procedures Sheet http://xbrl.sec.gov/ecd/role/InsiderTradingPoliciesProc Insider Trading Policies and Procedures Notes 21 false false R22.htm 995550 - Disclosure - Cybersecurity Risk Management and Strategy Disclosure Sheet http://xbrl.sec.gov/cyd/role/CybersecurityRiskManagementAndStrategyDisclosure Cybersecurity Risk Management and Strategy Disclosure Notes 22 false false R23.htm 9955511 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Sheet http://www.vallon-pharma.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPolicies SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Policies) Policies 23 false false R24.htm 9955512 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Sheet http://www.vallon-pharma.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESTables SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES (Tables) Tables http://www.vallon-pharma.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIES 24 false false R25.htm 9955513 - Disclosure - PROPERTY AND EQUIPMENT (Tables) Sheet http://www.vallon-pharma.com/role/PROPERTYANDEQUIPMENTTables PROPERTY AND EQUIPMENT (Tables) Tables http://www.vallon-pharma.com/role/PROPERTYANDEQUIPMENT 25 false false R26.htm 9955514 - Disclosure - LEASES (Tables) Sheet http://www.vallon-pharma.com/role/LEASESTables LEASES (Tables) Tables http://www.vallon-pharma.com/role/LEASES 26 false false R27.htm 9955515 - Disclosure - ACCRUED EXPENSES (Tables) Sheet http://www.vallon-pharma.com/role/ACCRUEDEXPENSESTables ACCRUED EXPENSES (Tables) Tables http://www.vallon-pharma.com/role/ACCRUEDEXPENSES 27 false false R28.htm 9955516 - Disclosure - STOCKHOLDERS EQUITY (Tables) Sheet http://www.vallon-pharma.com/role/STOCKHOLDERSEQUITYTables STOCKHOLDERS EQUITY (Tables) Tables http://www.vallon-pharma.com/role/STOCKHOLDERSEQUITY 28 false false R29.htm 9955517 - Disclosure - STOCK-BASED COMPENSATION (Tables) Sheet http://www.vallon-pharma.com/role/STOCKBASEDCOMPENSATIONTables STOCK-BASED COMPENSATION (Tables) Tables http://www.vallon-pharma.com/role/STOCKBASEDCOMPENSATION 29 false false R30.htm 9955518 - Disclosure - INCOME TAX (Tables) Sheet http://www.vallon-pharma.com/role/INCOMETAXTables INCOME TAX (Tables) Tables http://www.vallon-pharma.com/role/INCOMETAX 30 false false R31.htm 9955519 - Disclosure - ORGANIZATION AND DESCRIPTION OF BUSINESS (Details) Sheet http://www.vallon-pharma.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESSDetails ORGANIZATION AND DESCRIPTION OF BUSINESS (Details) Details http://www.vallon-pharma.com/role/ORGANIZATIONANDDESCRIPTIONOFBUSINESS 31 false false R32.htm 9955520 - Disclosure - LIQUIDITY (Details) Sheet http://www.vallon-pharma.com/role/LIQUIDITYDetails LIQUIDITY (Details) Details http://www.vallon-pharma.com/role/LIQUIDITY 32 false false R33.htm 9955521 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Cash and Cash Equivalents (Details) Sheet http://www.vallon-pharma.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESCashandCashEquivalentsDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Cash and Cash Equivalents (Details) Details 33 false false R34.htm 9955522 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property and Equipment (Details) Sheet http://www.vallon-pharma.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESPropertyandEquipmentDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Property and Equipment (Details) Details 34 false false R35.htm 9955523 - Disclosure - SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Diluted Net Loss Per Common Share (Details) Sheet http://www.vallon-pharma.com/role/SUMMARYOFSIGNIFICANTACCOUNTINGPOLICIESScheduleofDilutedNetLossPerCommonShareDetails SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES - Schedule of Diluted Net Loss Per Common Share (Details) Details 35 false false R36.htm 9955524 - Disclosure - PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details) Sheet http://www.vallon-pharma.com/role/PROPERTYANDEQUIPMENTScheduleofPropertyandEquipmentDetails PROPERTY AND EQUIPMENT - Schedule of Property and Equipment (Details) Details 36 false false R37.htm 9955525 - Disclosure - PROPERTY AND EQUIPMENT - Narrative (Details) Sheet http://www.vallon-pharma.com/role/PROPERTYANDEQUIPMENTNarrativeDetails PROPERTY AND EQUIPMENT - Narrative (Details) Details 37 false false R38.htm 9955526 - Disclosure - LEASES - Schedule of Operating Lease Assets and Liabilities (Details) Sheet http://www.vallon-pharma.com/role/LEASESScheduleofOperatingLeaseAssetsandLiabilitiesDetails LEASES - Schedule of Operating Lease Assets and Liabilities (Details) Details 38 false false R39.htm 9955527 - Disclosure - LEASES - Schedule of Future Minimum Lease Payments (Details) Sheet http://www.vallon-pharma.com/role/LEASESScheduleofFutureMinimumLeasePaymentsDetails LEASES - Schedule of Future Minimum Lease Payments (Details) Details 39 false false R40.htm 9955528 - Disclosure - LEASES - Narrative (Details) Sheet http://www.vallon-pharma.com/role/LEASESNarrativeDetails LEASES - Narrative (Details) Details 40 false false R41.htm 9955529 - Disclosure - ACCRUED EXPENSES (Details) Sheet http://www.vallon-pharma.com/role/ACCRUEDEXPENSESDetails ACCRUED EXPENSES (Details) Details http://www.vallon-pharma.com/role/ACCRUEDEXPENSESTables 41 false false R42.htm 9955530 - Disclosure - STOCKHOLDERS??? EQUITY - Narrative (Details) Sheet http://www.vallon-pharma.com/role/STOCKHOLDERSEQUITYNarrativeDetails STOCKHOLDERS??? EQUITY - Narrative (Details) Details 42 false false R43.htm 9955531 - Disclosure - STOCKHOLDERS??? EQUITY - Schedule of Estimate of the Fair Value of the Warrants and Assumptions (Details) Sheet http://www.vallon-pharma.com/role/STOCKHOLDERSEQUITYScheduleofEstimateoftheFairValueoftheWarrantsandAssumptionsDetails STOCKHOLDERS??? EQUITY - Schedule of Estimate of the Fair Value of the Warrants and Assumptions (Details) Details 43 false false R44.htm 9955532 - Disclosure - STOCKHOLDERS??? EQUITY - Schedule of Warrants Outstanding to Purchase Common Stock (Details) Sheet http://www.vallon-pharma.com/role/STOCKHOLDERSEQUITYScheduleofWarrantsOutstandingtoPurchaseCommonStockDetails STOCKHOLDERS??? EQUITY - Schedule of Warrants Outstanding to Purchase Common Stock (Details) Details 44 false false R45.htm 9955533 - Disclosure - STOCK-BASED COMPENSATION - Narrative (Details) Sheet http://www.vallon-pharma.com/role/STOCKBASEDCOMPENSATIONNarrativeDetails STOCK-BASED COMPENSATION - Narrative (Details) Details 45 false false R46.htm 9955534 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Stock-based Compensation Expense (Details) Sheet http://www.vallon-pharma.com/role/STOCKBASEDCOMPENSATIONScheduleofStockbasedCompensationExpenseDetails STOCK-BASED COMPENSATION - Schedule of Stock-based Compensation Expense (Details) Details 46 false false R47.htm 9955535 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Activity of Stock Options (Details) Sheet http://www.vallon-pharma.com/role/STOCKBASEDCOMPENSATIONScheduleofActivityofStockOptionsDetails STOCK-BASED COMPENSATION - Schedule of Activity of Stock Options (Details) Details 47 false false R48.htm 9955536 - Disclosure - STOCK-BASED COMPENSATION - Schedule of Assumptions Used to Estimate Fair Value of Options (Details) Sheet http://www.vallon-pharma.com/role/STOCKBASEDCOMPENSATIONScheduleofAssumptionsUsedtoEstimateFairValueofOptionsDetails STOCK-BASED COMPENSATION - Schedule of Assumptions Used to Estimate Fair Value of Options (Details) Details 48 false false R49.htm 9955537 - Disclosure - SEGMENT REPORTING (Details) Sheet http://www.vallon-pharma.com/role/SEGMENTREPORTINGDetails SEGMENT REPORTING (Details) Details http://www.vallon-pharma.com/role/SEGMENTREPORTING 49 false false R50.htm 9955538 - Disclosure - COMMITMENTS AND CONTINGENCIES (Details) Sheet http://www.vallon-pharma.com/role/COMMITMENTSANDCONTINGENCIESDetails COMMITMENTS AND CONTINGENCIES (Details) Details http://www.vallon-pharma.com/role/COMMITMENTSANDCONTINGENCIES 50 false false R51.htm 9955539 - Disclosure - INCOME TAX - Reconciliation of Federal Statutory Income Tax Rate to the Effective Income Tax Rate (Details) Sheet http://www.vallon-pharma.com/role/INCOMETAXReconciliationofFederalStatutoryIncomeTaxRatetotheEffectiveIncomeTaxRateDetails INCOME TAX - Reconciliation of Federal Statutory Income Tax Rate to the Effective Income Tax Rate (Details) Details 51 false false R52.htm 9955540 - Disclosure - INCOME TAX - Components of Deferred Taxes (Details) Sheet http://www.vallon-pharma.com/role/INCOMETAXComponentsofDeferredTaxesDetails INCOME TAX - Components of Deferred Taxes (Details) Details 52 false false R53.htm 9955541 - Disclosure - INCOME TAX - Narrative (Details) Sheet http://www.vallon-pharma.com/role/INCOMETAXNarrativeDetails INCOME TAX - Narrative (Details) Details 53 false false R54.htm 9955542 - Disclosure - SUBSEQUENT EVENTS (Details) Sheet http://www.vallon-pharma.com/role/SUBSEQUENTEVENTSDetails SUBSEQUENT EVENTS (Details) Details http://www.vallon-pharma.com/role/SUBSEQUENTEVENTS 54 false false All Reports Book All Reports ck0001824293-20251231.htm ck0001824293-20251231.xsd ck0001824293-20251231_cal.xml ck0001824293-20251231_def.xml ck0001824293-20251231_lab.xml ck0001824293-20251231_pre.xml ck0001824293-20251231_g1.jpg ck0001824293-20251231_g10.jpg ck0001824293-20251231_g11.jpg ck0001824293-20251231_g12.jpg ck0001824293-20251231_g13.jpg ck0001824293-20251231_g14.jpg ck0001824293-20251231_g15.jpg ck0001824293-20251231_g16.jpg ck0001824293-20251231_g2.jpg ck0001824293-20251231_g3.jpg ck0001824293-20251231_g4.jpg ck0001824293-20251231_g5.jpg ck0001824293-20251231_g6.jpg ck0001824293-20251231_g7.jpg ck0001824293-20251231_g8.jpg ck0001824293-20251231_g9.jpg http://fasb.org/us-gaap/2025 http://xbrl.sec.gov/cyd/2025 http://xbrl.sec.gov/dei/2025 http://xbrl.sec.gov/ecd/2025 true true